The iShares MSCI EAFE Value ETF aims to replicate the MSCI EAFE Value Index, focusing on developed-market stocks that display value traits such as lower price-to-book and price-to-earnings multiples. It typically allocates at least 80% of assets to index constituents, providing geographic spread across markets including Japan, the United Kingdom, France, Germany, Switzerland, and Australia.
With approximately 420 holdings, EFV serves as a sizable, liquid, and passively managed option. Top positions feature names like HSBC, Shell, Nestlé, Mitsubishi UFJ Financial Group, Roche, Allianz, Novartis, Toyota, TotalEnergies, and Siemens. Financials make up about 40% of the sector allocation, with industrials near 10%, consumer staples around 9%, healthcare roughly 7.5%, and energy about 7%. Technology holds only a modest single-digit share, distinguishing EFV from growth-tilted international funds. The net expense ratio stands at 0.31%.
EFV sits at the overlap of international diversification and value investing. Following an extended period of U.S. mega-cap technology dominance, many investors have turned overseas in search of better relative valuations, solid dividend yields, and access to cyclical sectors linked to global growth.
The fund's emphasis on financials ties its results to the global banking environment, where higher-for-longer rates have often bolstered net interest margins for European and Japanese lenders. Energy and materials exposure connects performance to commodity prices and industrial demand, while the limited technology allocation reduces sensitivity to AI-related swings that have affected U.S. large-cap growth. I also checked this using Tickeron’s AI Screener to see how the fund compares to peers on sector and risk metrics. Monetary policy, inflation trends, and currency movements, especially the U.S. dollar, remain central influences.
EFV's price movement lately shows consolidation more than a strong directional move. On a split-adjusted basis, the 30-day return has been roughly flat to slightly positive after a 2-for-1 share split effective in early November 2026, which halved the nominal price without changing underlying value. Investors reviewing price charts should adjust for this action when making comparisons.
Over a longer period, the positioning has proven supportive. International value equities delivered a year-to-date gain of roughly 13%, aided by steady bank earnings, consistent dividends from multinational staples and healthcare holdings, and a broader rotation toward lower-valued developed-market stocks. The leading positions, anchored by HSBC, Shell, and Mitsubishi UFJ, underscore a focus on income and cyclical recovery rather than elevated multiples, which has aided navigation through periods of high U.S. equity valuations.
Several elements are poised to influence EFV's path in the year ahead. The global interest-rate environment stays key: sustained or rising rates tend to support bank margins and value equities, whereas rapid easing might favor growth and technology at the expense of value. Inflation patterns and central-bank actions in the eurozone, Japan, and the United Kingdom merit attention, along with currency trends, particularly a firm U.S. dollar that can reduce returns on unhedged international holdings.
Earnings trends among major financial holdings carry extra weight due to the sector's large allocation. Commodity prices will affect the energy and materials portions, and regulatory or capital-market developments in European and Japanese banks could sway sentiment. Ongoing competition among low-cost international value ETFs and the wider discussion on U.S. versus international leadership will also guide institutional flows. These dynamics bring both potential opportunities and risks, without pointing to any particular price outcome.
When evaluating funds like EFV, I often rely on Tickeron's AI Screener to cross-check sector exposures, performance traits, and risk measures against comparable ETFs. The platform helps surface relevant data points quickly and supports a more structured review process without replacing core due diligence.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The RSI Indicator for EFV moved into overbought territory on November 05, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Following a +0.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where EFV advanced for three days, in 292 of 339 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
EFV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 59 cases where EFV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 71%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EFV as a result. In 62 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
The Moving Average Convergence Divergence Histogram (MACD) for EFV turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 38 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
EFV moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EFV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for EFV entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ForeignLargeValue